文献速递泌尿生殖腹部CT

快速千伏切换双能CT衰减差与碘浓度阈值诊断肾脏肿块强化的准确性

Diagnostic Accuracy of Attenuation Difference and Iodine Concentration Thresholds at Rapid-Kilovoltage-Switching Dual-Energy CT for Detection of Enhancement in Renal Masses.
PubMed 文献 · AJR Am J Roentgenol · 2019-05-23

研究纳入30个经组织学证实的实性肾脏肿块和27个良性囊肿,在快速千伏切换双能CT上评估碘浓度和HU差值阈值诊断强化的准确性。皮髓质期碘浓度≥1.2 mg/mL或70-keV ΔHU≥15 HU的敏感度分别为86.7%和90.0%,特异度均为100.0%,AUC分别为0.93和0.95,且无囊肿假性强化。

要点

  • 皮髓质期碘浓度≥1.2 mg/mL诊断肾脏肿块强化:敏感度86.7%、特异度100.0%、AUC 0.93。
  • 皮髓质期70-keV ΔHU≥15 HU诊断肾脏肿块强化:敏感度90.0%、特异度100.0%、AUC 0.95。
  • 肾图期ΔHU≥15 HU敏感度100.0%但特异度降至88.9%,11.1%(3/27)囊肿出现假性强化。

核心结论

  • 皮髓质期双能CT采用碘浓度≥1.2 mg/mL或70-keV ΔHU≥15 HU诊断肾脏肿块强化表现最佳,提高敏感度且无囊肿假性强化。

研究设计与样本

  • 研究纳入30个连续经组织学证实的实性肾脏肿块(含9个乳头状肾细胞癌)和27个良性囊肿(17个单纯囊肿、10个出血或蛋白性囊肿),2016年12月至2018年5月行双能CT检查;由一名盲法放射科医师在70-keV皮髓质期虚拟单能图像和120-kVp肾图期图像上测量碘浓度和ΔHU,用ROC曲线比较既往报道的强化阈值。

关键影像表现/征象

  • 双能CT皮髓质期测量碘浓度和70-keV ΔHU用于区分强化实性肿块与囊肿,皮髓质期未见囊肿假性强化。
  • 120-kVp肾图期ΔHU≥15 HU时11.1%(3/27)囊肿出现假性强化,ΔHU≥20 HU时1个囊肿出现假性强化。
  • 乳头状肾细胞癌在皮髓质期碘浓度≥2.0 mg/mL时77.8%(7/9,范围0.7-1.6 mg/mL)被错误分类,碘浓度≥1.2 mg/mL时44.4%(4/9,范围0.7-0.9 mg/mL)被错误分类。
  • 乳头状肾细胞癌在皮髓质期70-keV ΔHU≥20 HU时66.7%(6/9,范围4-17 HU)被错误分类,ΔHU≥15 HU时33.3%(3/9,范围4-12 HU)被错误分类;肾图期ΔHU≥20 HU时22.2%(2/9,范围15-18 HU)被错误分类,ΔHU≥15 HU时无误分类。

诊断标准与关键数值

  • 皮髓质期碘浓度≥2.0 mg/mL诊断强化:敏感度73.3%、特异度100.0%、AUC 0.87。
  • 皮髓质期碘浓度≥1.2 mg/mL诊断强化:敏感度86.7%、特异度100.0%、AUC 0.93。
  • 皮髓质期70-keV ΔHU≥20 HU诊断强化:敏感度80.0%、特异度100.0%、AUC 0.90。
  • 皮髓质期70-keV ΔHU≥15 HU诊断强化:敏感度90.0%、特异度100.0%、AUC 0.95。
  • 肾图期120-kVp ΔHU≥20 HU诊断强化:敏感度93.3%、特异度96.3%、AUC 0.95;ΔHU≥15 HU:敏感度100.0%、特异度88.9%、AUC 0.94。

临床应用与阅片要点

  • 皮髓质期碘浓度≥1.2 mg/mL或70-keV ΔHU≥15 HU可提高肾脏肿块强化检出敏感度且无囊肿假性强化。
  • 碘浓度≥2.0 mg/mL的准确性显著低于其他指标(p=0.031-0.045),阅片时不宜单独采用该阈值。
  • 肾图期ΔHU≥15 HU虽然敏感度高,但11.1%囊肿出现假性强化,需结合皮髓质期参数综合判断。
  • 乳头状肾细胞癌在较低阈值下仍可能被误判为无强化,需警惕其假阴性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The objective of our study was to evaluate iodine concentration and attenuation change in Hounsfield unit (ΔHU) thresholds to diagnose enhancement in renal masses at rapid-kilovoltage-switching dual-energy CT (DECT). MATERIALS AND METHODS. We evaluated 30 consecutive histologically confirmed solid renal masses (including nine papillary renal cell carcinomas [RCCs]) and 27 benign cysts (17 simple and 10 hemorrhagic or proteinaceous cysts) with DECT December 2016 and May 2018. A blinded radiologist measured iodine concentration (in milligrams per milliliter) and ΔHU (attenuation on enhanced CT - attenuation on unenhanced CT) using 70-keV corticomedullary (CM) phase virtual monochromatic and 120-kVp nephrographic (NG) phase images. The accuracies of previously described enhancement thresholds were compared by ROC curve analysis. RESULTS. An iodine concentration of ≥ 2.0 mg/mL and an iodine concentration of ≥ 1.2 mg/mL achieved sensitivity, specificity, and the area under the ROC curve (AUC) of 73.3%, 100.0%, and 0.87 and 86.7%, 100.0%, and 0.93, respectively. On 70-keV CM phase images, ΔHU ≥ 20 HU and ΔHU ≥ 15 HU yielded sensitivity, specificity, and AUC of 80.0%, 100.0%, and 0.90 and 90.0%, 100.0%, and 0.95, respectively. The numbers of incorrectly classified papillary RCCs were as follows: iodine concentration of ≥ 2.0 mg/mL, 77.8% (7/9; range, 0.7-1.6 mg/mL); iodine concentration of ≥ 1.2 mg/mL, 44.4% (4/9; range, 0.7-0.9 mg/mL); ΔHU ≥ 20 HU on 70-keV CM phase images, 66.7% (6/9; range, 4-17 HU); and ΔHU ≥ 15 HU on 70-keV DECT images, 33.3% (3/9; 4-12 HU). No cyst pseudoenhancement occurred on DECT. For 120-kVp NG phase DECT, ΔHU ≥ 20 HU and ΔHU ≥ 15 HU yielded sensitivity, specificity, and AUC of 93.3%, 96.3%, and 0.95 and 100.0%, 88.9%, and 0.94, respectively. With ΔHU ≥ 20 HU, 22.2% (2/9) (range, 15-18 HU) of papillary RCCs were misclassified and there was one pseudoenhancing cyst. With ΔHU ≥ 15 HU, no papillary RCCs were misclassified but 11.1% (3/27) of cysts showed pseudoenhancement. Only an iodine concentration of ≥ 2.0 mg/mL showed significantly lower accuracy than other measures (p = 0.031-0.045). CONCLUSION. DECT applied in the CM phase performed best using an iodine concentration of ≥ 1.2 mg/mL or a 70-keV ΔHU ≥ 15 HU; these parameters improved sensitivity for the detection of enhancement in renal masses without instances of cyst pseudoenhancement.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Sadoughi N, Krishna S, Macdonald DB, et al. Diagnostic Accuracy of Attenuation Difference and Iodine Concentration Thresholds at Rapid-Kilovoltage-Switching Dual-Energy CT for Detection of Enhancement in Renal Masses. AJR Am J Roentgenol. 2019. PMID: 31120787. doi:10.2214/AJR.18.20990

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。